Pfizer Inc. (PFE) — Stock Price, Chart & Analysis
Pfizer Inc. (PFE) is a Healthcare stock currently trading at $27.67, up 9.74% on the day. It carries a market capitalization of $159.19B and a trailing P/E ratio of 36.27. Over the past 52 weeks, PFE has traded between $23.58 and $29.21. Pfizer Inc. pays a dividend yielding 6.2%. View the live PFE chart, technical opinion, analyst ratings, fundamentals and latest news below.
Pfizer Inc. (PFE) key data
| Price | $27.67 |
| Change (today) | +9.74% |
| Previous close | $25.21 |
| Market cap | $159.19B |
| P/E ratio (TTM) | 36.27 |
| EPS (TTM) | $0.77 |
| Dividend yield | 6.2% |
| 52-week high | $29.21 |
| 52-week low | $23.58 |
| Beta | 0.30 |
| Avg. volume | 39.96M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about Pfizer Inc. (PFE)
How much does one share of Pfizer Inc. cost?
As of the latest update, one share of Pfizer Inc. (PFE) trades at $27.67 (+9.74% today).
What is Pfizer Inc.'s market cap?
Pfizer Inc. has a market capitalization of approximately $159.19B.
What is Pfizer Inc.'s P/E ratio?
Pfizer Inc. has a trailing price-to-earnings (P/E) ratio of 36.27.
What is Pfizer Inc.'s earnings per share (EPS)?
Pfizer Inc.'s trailing twelve-month EPS is $0.77.
Does Pfizer Inc. pay a dividend?
Yes — Pfizer Inc. pays a dividend with a yield of 6.2% ($1.72 per share annually).
What is Pfizer Inc.'s 52-week trading range?
Over the past year, PFE has traded between $23.58 and $29.21.
What is the analyst price target for Pfizer Inc.?
The mean analyst price target for Pfizer Inc. is $28.88. This is informational only and not investment advice.
Latest Pfizer Inc. (PFE) news
- Pfizer, Kraft, and UPS All Yield More Than 6%. Which of These Dividend Stocks Is the Safest Option Today?News · Sep 23, 2026
- Pfizer (PFE) Stock May Be Overvalued After Overseas Pricing DealNews · Sep 23, 2026
- Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?News · Sep 22, 2026
- Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with AnalystsNews · Sep 22, 2026
- AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?News · Sep 22, 2026
- How Investors Are Reacting To Pfizer (PFE) Easing Policy Pressures And New HHS Revenue-Sharing DealNews · Sep 21, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live PFE dashboard…